To verify whether the telmisartan modulates PPARα, PPARδ and RELA to influence NAFLD network, the protein levels of these transcription factors and the mRNA levels of their downstream target genes were evaluated in Hepa1c1c7 cells. This evidence concerns the gene PPARD and metabolic dysfunction-associated steatotic liver disease.